Villringer, Arno Department Neurology, MPI for Human Cognitive and Brain Sciences, Max Planck Society;
Kappos, L., Freedman, M. S., Polman, C. H., Edan, G., Hartung, H.-P., Miller, D. H., et al. (2009). Long-term effect of early treatment with interferon beta-1b after a first clinical event suggestive of multiple sclerosis: 5-year active treatment extension of the phase 3 BENEFIT trial. Lancet Neurology, 8(11), 987-997. doi:10.1016/S1474-4422(09)70237-6.